At GlaxoSmithKline Ian currently focuses on the execution of corporate and business development projects in the Pharmaceutical, Vaccines, and Consumer Healthcare businesses. Ian has worked on early stage research collaborations, clinical stage development assets, and commercial collaborations of marketed products. Ian started his career with Merck as a biochemist in Oncology drug discovery focused on a program in the signal transduction pathway that resulted in a clinical stage asset. After working as a sales representative for Eli Lilly, Ian took on marketing and finance roles that supported strategy planning and business development at Bristol-Myers Squibb before transitioning into business development. Ian gained experience in business development at Bristol-Myers Squibb as a director on both the transactions team and the search and evaluation team focusing on innovative R&D discovery projects and clinical stage assets.
